ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,942Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 14

$768K Total Retail Price of All Prescriptions

Rank: 1 out of 14

394 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 394 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 14,590 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
FUROSEMIDE 699 630 1 6
SIMVASTATIN 569 428 2 3
OMEPRAZOLE 545 508 3 4
POTASSIUM CHLORIDE 467 367 4 15
LEVOTHYROXINE SODIUM 452 418 5 2
AMLODIPINE BESYLATE 419 357 6 5
TRAMADOL HCL 353 308 7 11
MELOXICAM 341 298 8 12
GABAPENTIN 320 293 9 9
METOPROLOL TARTRATE 300 269 10 17
PRAVASTATIN SODIUM 298 266 11 21
HYDROCODONE-ACETAMINOPHEN 296 263 S3 12 1
HYDROCHLOROTHIAZIDE 282 228 13 13
GLIMEPIRIDE 279 245 14 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 272 228 15 14
METFORMIN HCL 255 209 16 8
NAMENDA 243 243 17 25
NEXIUM 228 170 18 16
CLONIDINE HCL 221 146 19 40
ALLOPURINOL 221 181 19 43
LISINOPRIL 220 201 21 7
LOSARTAN-HYDROCHLOROTHIAZIDE 208 151 22 30
DONEPEZIL HCL 193 193 23 23
METOCLOPRAMIDE HCL 183 147 24 54
WARFARIN SODIUM 181 164 25 31
ESCITALOPRAM OXALATE 180 156 26 35
CARVEDILOL 171 133 27 29
TRAMADOL HCL-ACETAMINOPHEN 146 146 28 67
SERTRALINE HCL 136 133 29 26
ATORVASTATIN CALCIUM 136 125 29 19
ALENDRONATE SODIUM 132 120 31 72
LOVAZA 132 88 31 54
DIOVAN HCT 123 99 33 56
TAMSULOSIN HCL 122 108 34 32
ISOSORBIDE MONONITRATE ER 117 117 35 77
RANITIDINE HCL 116 112 36 57
VERAPAMIL ER 115 101 37 81
METOPROLOL SUCCINATE 115 89 37 24
ZOLPIDEM TARTRATE 111 101 39 10
LYRICA 108 84 40 87
CRESTOR 101 88 41 45
KLOR-CON 10 98 89 42 90
ROPINIROLE HCL 96 89 43 91
ATENOLOL 95 64 44 28
CLOPIDOGREL 94 90 45 51
RESTASIS 93 93 46 92
PLAVIX 90 88 47 66
CITALOPRAM HBR 90 81 47 18
FLUOXETINE HCL 90 74 47 71
AMITRIPTYLINE HCL 89 86 R 50 93
LEXAPRO 85 70 51 98
SPIRONOLACTONE 85 73 51 98
LACTULOSE 84 56 53 101
CYMBALTA 80 68 54 39
PRENATAL PLUS 79 69 55 103
CIPROFLOXACIN HCL 78 70 56 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 63 57 49
CARBIDOPA-LEVODOPA 74 58 58 107
LOSARTAN POTASSIUM 74 65 58 22
COLCRYS 73 63 60 108
CYCLOBENZAPRINE HCL 71 40 R 61 52
MECLIZINE HCL 70 70 62 112
CEPHALEXIN 67 67 63 114
BYSTOLIC 65 61 64 115
BENICAR HCT 64 64 65 117
PANTOPRAZOLE SODIUM 64 40 65 53
ONGLYZA 64 55 65 117
SYMBICORT 63 48 68 120
KETOPROFEN 62 43 69 123
EXELON 61 61 70 125
DILTIAZEM 24HR ER 61 61 70 125
MOMETASONE FUROATE 60 56 72 127
AMLODIPINE BESYLATE-BENAZEPRIL 59 59 73 42
GLIPIZIDE XL 58 58 74 128
MEGESTROL ACETATE 57 57 R 75 130
POLYETHYLENE GLYCOL 3350 52 50 76 58
NAPROXEN 52 50 76 84
LOVASTATIN 51 41 78 37
HYDRALAZINE HCL 50 36 79 138
MIRTAZAPINE 50 50 79 44
DIVALPROEX SODIUM 50 50 79 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.